终结糖尿病污名与歧视:基于证据和建议的国际共识声明
国际多学科专家小组(51名成员,来自18个国家)通过快速综述和三轮德尔菲调查,就25条证据声明和24条建议声明达成共识。共识指出糖尿病污名主要由指责、负担或疾病感知、隐形化及恐惧或厌恶驱动;平均每5名成人糖尿病患者中4人经历污名、1人经历歧视;污名与歧视有害、不可接受、不道德且适得其反,需集体领导主动挑战并终结。
要点
- 平均每5名成人糖尿病患者中4人经历糖尿病污名,1人因糖尿病经历歧视。
- 糖尿病污名主要由指责、负担或疾病感知、隐形化及恐惧或厌恶驱动。
- 专家小组一致同意承诺终结糖尿病污名与歧视。
核心结论
- 糖尿病污名与歧视有害、不可接受、不道德且适得其反,需要集体领导主动挑战并终结。
研究设计与样本
- 国际多学科专家小组(51名成员,来自18个国家)开展快速综述并参与三德尔菲调查流程。
主要发现
- 平均每5名成人糖尿病患者中4人经历糖尿病污名,1人因糖尿病经历歧视,如医疗、教育和就业领域。
关键数值与推荐
- 就25条证据声明和24条建议声明达成共识。
- 就终结糖尿病污名与歧视的承诺达成一致共识。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
People with diabetes often encounter stigma (ie, negative social judgments, stereotypes, prejudice), which can adversely affect emotional, mental, and physical health; self-care, access to optimal health care; and social and professional opportunities. To accelerate an end to diabetes stigma and discrimination, an international multidisciplinary expert panel (n=51 members, from 18 countries) conducted rapid reviews and participated in a three-round Delphi survey process. We achieved consensus on 25 statements of evidence and 24 statements of recommendations. The consensus is that diabetes stigma is driven primarily by blame, perceptions of burden or sickness, invisibility, and fear or disgust. On average, four in five adults with diabetes experience diabetes stigma and one in five experience discrimination (ie, unfair and prejudicial treatment) due to diabetes, such as in health care, education, and employment. Diabetes stigma and discrimination are harmful, unacceptable, unethical, and counterproductive. Collective leadership is needed to proactively challenge, and bring an end to, diabetes stigma and discrimination. Consequently, we achieved unanimous consensus on a pledge to end diabetes stigma and discrimination.
引用
- Speight J, Holmes-Truscott E, Garza M, et al. Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations. Lancet Diabetes Endocrinol. 2024. PMID: 38128969. doi:10.1016/S2213-8587(23)00347-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。